ag

Literature

Literature von Willebrand

Poster

  • Van Haren B. et al. 
    Evaluation of 3 Collagen Binding Assays and correlation with other VWF parameters
    GTH 2010, Nürnberg





PDF_Icon 

  • Geiter S. et al. 
    ADAMTS-13 activity, ADAMTS-13 and vWF antigen concentration and the risk of myocardial infarction
    ISTH 2009, Boston
     


PDF_Icon 

  • Stadler M. et al. 
    Evaluation of von Willebrand factor (VWF) concentrate activity assays employing different collagen types 
    WFH Istanbul 2008

 


PDF_Icon 

  • Siegemund A. et al. 
    Collagen type I and collagen type III as coating material for collagen binding assays.
    GTH Basel 2006, P278

 


PDF_Icon 
  • Gruber G et. al. 
    Effective removal of ADAMTS13 by the manufacturing process of Wilate, a high-purity and double virus inactivated VWF/FVIII concentrate.
    GTH Basel 2006, P371


PDF_Icon 
  • Maguire SJ et al. 
    Collagen Binding Assays: An alternative to the Ristocetin Cofactor ?
    IBMS 2003


PDF_Icon 

Literature

  • Emmanuel J. Favaloro
    Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease
    Schattauer 2010 Blood Coagulation, Fibrinolysis and Cellular Haemostasis, 1009-1021





PDF_Icon 

  • J. S. O'Donell et al. 
    Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis
    Blood, 15. September 2005, Volume 106, Number 6, 1988-1991


PDF_Icon 

  • J. SIEKMANN, et al. 
    The determination of von Willebrand factor activity by collagen binding assay.
    Haemophilia (1998), 4 (Suppl. 3), 15-24

 


PDF_Icon